Increasing levels of obesity within women of reproductive age is a major concern in the UK. Approximately, 13% of women aged !30 and 22% of 31-to 40-year-old women are obese. Obesity increases complications during pregnancy and the risk of caesarean section due to prolonged labour and poor uterine activity. The aim was to investigate whether a high-fat, high-cholesterol (HFHC) diet decreases markers of uterine contractility during parturition in the rat. Female Wistar rats were fed control (CON, nZ10) or HFHC (nZ10) diets for 6 weeks. Animals were mated and, once pregnant, maintained on their diet throughout gestation. On gestational day 19, rats were monitored continuously and killed at the onset of parturition. Body and fat depot weights were recorded. Myometrial tissue was analysed for cholesterol (CHOL), triglycerides (TAG), and expression of the contractile associated proteins gap junction protein alpha 1 (GJA1; also known as connexin-43, CX-43), prostaglandin-endoperoxide synthase 2 (PTGS2; also known as cyclo-oxygenase-2, COX-2) and caveolin-1 (CAV1) and maternal plasma for prostaglandin F 2a (PGF 2a ) and progesterone. HFHC fed rats gained greater weight than CON (P!0.003) with significant increases in peri-renal fat (P!0.01). The HFHC diet increased plasma CHOL, TAG and progesterone, but decreased PGF 2a versus CON (P!0.01, P!0.01, PZ0.05 and P!0.02 respectively). Total CHOL and TAG levels of uterine tissue were similar. However, HFHC fed rats showed significant increases in PTGS2 (P!0.037), but decreases in GJA1 and CAV1 (PZ0.059). In conclusion, a HFHC diet significantly increases body weight and alters lipid profiles that correlate with decreases in key markers of uterine contractility. Further work is required to ascertain whether these changes have adverse effects on uterine activity.

Low glycemic index (GI) and/or low glycemic load (GL) are associated with decreased risks of type-2 diabetes and cardiovascular disease. It is therefore relevant to consider GI and GL in the early phases of the development of packaged foods and beverages. This paper proposes a model that predicts GI and GL from macronutrient composition, by quantifying both the impact of glycemic carbohydrates and the GI-lowering effects of nutrients such as proteins, fats and fibers. The precision of the model is illustrated using data on 42 breakfast cereals. The predictions of GI (r = 0.90, median residual = 2.0) and GL (r = 0.96, median residual = 0.40 g) compete well with the precision of the underlying in-vivo data (Standard Error SE = 3.5 for GI). This model can guide product development towards lowering GI and GL, before final confirmation by in vivo testing.

Sleep is involved in metabolic, emotional and cognitive regulation and is therefore an essential part of our health. Although an association between sleep quality and macronutrient intake has been reported, studies on the effect of macronutrient distribution with sleep quality are limited, and available results are inconsistent. In this study, we aim to assess the association between sleep quality and macronutrient distribution in healthy adults from systematically reviewed cross-sectional studies and randomized controlled trials (RCTs). A total of 19 relevant articles were selected and it was observed that good sleepers (sleep duration ≥ 7 h, global sleep score ≤ 5, sleep latency ≤ 30 min and sleep efficiency >85%) had a higher energy distribution from dietary protein than poor sleepers. On the other hand, good sleepers showed a relatively lower percentage of energy from dietary carbohydrate and fat than poor sleepers. However, meta-regression analysis revealed no dose-dependent association between the macronutrient distributions and sleep duration. These results suggest that consuming a greater proportion of dietary protein may benefit on improving sleep quality in healthy adults. However, findings may be susceptible to reverse causality and additional RCTs are needed.

Incorporating zeaxanthin-rich wolfberry (Lycium barbarum) into a healthy dietary pattern may augment its antioxidant potential. The present 16-week, parallel design randomized controlled trial aimed to investigate the impact of adhering to a healthy dietary pattern, either with or without whole dried wolfberry (15 g/d) on oxidative stress status (plasma malondialdehyde and 8-iso-prostaglandin F2α) in middle-aged and older adults. Changes to carotenoids status (plasma and skin carotenoids) and body composition were further evaluated to explore potential mechanisms which underlie the antioxidant properties of wolfberry. Plasma 8-iso-prostaglandin F2α, plasma zeaxanthin and skin carotenoids status were significantly raised in the wolfberry consuming group (n = 22; p < 0.05) compared to the control group which showed no changes (n = 18). Likewise in the wolfberry group only, inverse association was observed between the change values of plasma zeaxanthin and plasma 8-iso-prostaglandin F2α (−0.21 (−0.43, 0.00) ng/µmol, regression coefficient (95% CI); p = 0.05). Wolfberry consumption with a healthy dietary pattern may serve as a dietary strategy to attenuate lipid peroxidation among middle-aged and older adults who are at a heightened risk of oxidative stress induced age-related disorders. The antioxidant properties of wolfberry may be attributed to its rich zeaxanthin content.

Search string details (For EMBASE)('dietary fiber'/exp OR 'alimentary fiber':ti,ab OR 'diet fiber':ti,ab OR 'dietary fiber':ti,ab OR 'dietary fibre':ti,ab OR 'inulin'/de OR 'inuline':ti,ab OR 'pectin'/exp OR 'ispagula'/exp OR 'ispaghul':ti,ab OR 'ispaghula':ti,ab OR 'ispaghula husk':ti,ab OR 'ispagula':ti,ab OR 'isphagula':ti,ab OR 'plantago ovata extract':ti,ab OR 'plantago ovata seed ':ti,ab OR 'plantago seed':ti,ab OR 'plantago seed oil':ti,ab OR 'psyllium':ti,ab OR 'psyllium gum':ti,ab OR 'psyllium hemicellulose':ti,ab OR 'psyllium plantago':ti,ab OR 'psyllium seed':ti,ab OR 'psyllium seed gum':ti,ab OR 'psyllium seed husk':ti,ab OR 'cellulose'/de OR 'whole grain'/exp OR 'unrefined grain':ti,ab OR 'whole grain':ti,ab OR 'whole grains':ti,ab OR 'wholegrain':ti,ab OR 'wholegrains':ti,ab OR 'beta glucan'/exp OR 'beta glucan':ti,ab OR 'beta glucans':ti,ab OR 'beta-glucans':ti,ab OR 'non starch polysaccharide'/de OR 'fructose oligosaccharide'/exp OR 'fructo oligosaccharide' OR 'fructooligosaccharide' OR 'fructose oligosaccharide' OR 'oligofructose' OR 'galactose oligosaccharide'/exp OR 'galacto oligosaccharide':ti,ab OR 'galactooligosaccharide':ti,ab OR 'galactose oligomer':ti,ab OR 'galactose oligosaccharide':ti,ab OR 'oligogalactose':ti,ab OR 'resistant starch'/de OR 'arabinoxylan'/exp OR 'arabinoxylan':ti,ab OR 'xyloarabinan':ti,ab OR 'polydextrose'/de OR 'bran'/exp OR 'bran':ti,ab OR 'prebiotic agent'/exp OR 'prebiotic':ti,ab OR 'prebiotics':ti,ab OR 'lignin'/exp OR 'lignin':ti,ab OR 'lignine':ti,ab OR 'resistant oligosaccharide':ti,ab OR 'resistant dextrin':ti,ab OR 'resistant maltodextrin':ti,ab OR 'indigestible dextrin':ti,ab OR polyfructose:ti,ab OR 'soluble fibre':ti,ab OR 'soluble fiber'/de OR 'insoluble fiber'/de OR 'insoluble fibre':ti,ab) AND ('body composition'/exp OR 'body composition':ti,ab OR 'composition, body':ti,ab OR adiposity:ti,ab OR 'body fat'/exp OR 'body fat':ti,ab OR 'body lipid':ti,ab OR 'fat load':ti,ab OR 'fat, body':ti,ab OR cardiometabolic:ti,ab OR 'metabolic syndrome x'/exp OR 'insulin resistance syndrome':ti,ab OR 'metabolic syndrome':ti,ab OR 'metabolic syndrome x':ti,ab OR 'syndrome x, metabolic':ti,ab OR triglycerides:ti,ab OR 'high density lipoprotein cholesterol'/exp OR 'hdl cholesterol':ti,ab OR 'cholesterol, hdl':ti,ab OR 'high density lipoprotein cholesterol':ti,ab OR 'lipoproteins, hdl cholesterol':ti,ab OR 'blood pressure'/exp OR 'blood pressure':ti,ab OR 'blood tension':ti,ab OR 'pressure, blood':ti,ab OR 'glucose blood level'/exp OR 'blood glucose':ti,ab OR 'blood glucose level':ti,ab OR 'blood serum glucose':ti,ab OR 'blood sugar':ti,ab OR 'blood sugar level ':ti,ab OR 'glucosaemia':ti,ab OR 'glucose blood level':ti,ab OR 'glucose, blood':ti,ab OR 'glucose, plasma':ti,ab OR 'glucosemia':ti,ab OR 'glycaemia':ti,ab OR 'glycemia':ti,ab OR 'plasma glucose':ti,ab OR 'serum glucose':ti,ab OR 'serum sugar':ti,ab OR 'waist circumference'/exp OR 'waist circumference':ti,ab OR 'waist hip ratio'/exp OR 'waist hip ratio':ti,ab OR 'waist to hip ratio':ti,ab OR 'waist-hip ratio'...